{"id":"NCT01023581","sponsor":"Takeda","briefTitle":"Efficacy and Safety of Alogliptin Plus Metformin in Patients With Type 2 Diabetes","officialTitle":"A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of Alogliptin Plus Metformin, Alogliptin Alone, or Metformin Alone in Subjects With Type 2 Diabetes","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-11","primaryCompletion":"2011-06","completion":"2011-06","firstPosted":"2009-12-02","resultsPosted":"2013-03-26","lastUpdate":"2013-03-26"},"enrollment":784,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes Mellitus, Type 2"],"interventions":[{"type":"DRUG","name":"Alogliptin","otherNames":["SYR-322"]},{"type":"DRUG","name":"Metformin","otherNames":["Glucophage","Glucophage XR","Riomet","Fortamet","Glumetza","Obimet","Dianben","Diabex","Diaformin"]},{"type":"DRUG","name":"Alogliptin Placebo","otherNames":[]},{"type":"DRUG","name":"Metformin Placebo","otherNames":[]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Alogliptin 25 QD","type":"EXPERIMENTAL"},{"label":"Alogliptin 12.5 BID","type":"EXPERIMENTAL"},{"label":"Metformin 500 BID","type":"ACTIVE_COMPARATOR"},{"label":"Metformin 1000 BID","type":"ACTIVE_COMPARATOR"},{"label":"Alogliptin 12.5 BID + Metformin 500 BID","type":"EXPERIMENTAL"},{"label":"Alogliptin 12.5 BID + Metformin 1000 BID","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to evaluate the safety and effectiveness of alogliptin combined with metformin, once daily (QD) or twice daily (BID), in participants with Type 2 Diabetes.","primaryOutcome":{"measure":"Change From Baseline in Glycosylated Hemoglobin (HbA1c) at Week 26","timeFrame":"Baseline and Week 26.","effectByArm":[{"arm":"Placebo","deltaMin":0.15,"sd":0.094},{"arm":"Alogliptin 25 QD","deltaMin":-0.52,"sd":0.094},{"arm":"Alogliptin 12.5 BID","deltaMin":-0.56,"sd":0.093},{"arm":"Metformin 500 BID","deltaMin":-0.65,"sd":0.094},{"arm":"Metformin 1000 BID","deltaMin":-1.11,"sd":0.092},{"arm":"Alogliptin 12.5 BID + Metformin 500 BID","deltaMin":-1.22,"sd":0.094},{"arm":"Alogliptin 12.5 BID + Metformin 1000 BID","deltaMin":-1.55,"sd":0.09}],"pValues":[{"comp":"OG002 vs OG005","p":"<0.001"},{"comp":"OG003 vs OG005","p":"<0.001"},{"comp":"OG002 vs OG006","p":"<0.001"},{"comp":"OG004 vs OG006","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":8,"exclusionCount":17},"locations":{"siteCount":201,"countries":["United States","Czechia","Hungary","Israel","Lithuania","Mexico","Poland","Puerto Rico","Romania","Russia","Slovakia","South Africa","Ukraine"]},"refs":{"pmids":["24400655"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":106},"commonTop":["Hyperglycaemia","Headache","Diarrhoea","Dyslipidaemia","Hypertension"]}}